2021 annual financial data
Niagen Bioscience, Inc. 2021 Operating margin
Niagen Bioscience, Inc. 2021 operating margin with verified reported values.
Direct answer
Operating margin was -40.14%.
Operating income was -27,073,000 USD and net income was -27,128,000 USD.
Operating cash flow was -24,163,000 USD.
Get free Niagen Bioscience, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 67,449,000 USD
- Operating income
- -27,073,000 USD
- Net income
- -27,128,000 USD
- Operating cash flow
- -24,163,000 USD